Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Complications after prostate biopsy: data from SEER-Medicare.

Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM.

J Urol. 2011 Nov;186(5):1830-4. doi: 10.1016/j.juro.2011.06.057. Epub 2011 Sep 23.

PMID:
21944136
3.

Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.

Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM.

J Urol. 2013 Mar;189(3):867-70. doi: 10.1016/j.juro.2012.10.005. Epub 2012 Oct 9.

4.

Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.

Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schröder FH, Roobol MJ.

Eur Urol. 2012 Jun;61(6):1110-4. doi: 10.1016/j.eururo.2011.12.058. Epub 2012 Jan 5.

PMID:
22244150
5.

Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.

Welch HG, Fisher ES, Gottlieb DJ, Barry MJ.

J Natl Cancer Inst. 2007 Sep 19;99(18):1395-400. Epub 2007 Sep 11.

PMID:
17848671
6.

The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.

Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O'Sullivan M, Livingston J, Sogani P, Eastham J, Scardino P, Touijer K.

J Urol. 2014 Mar;191(3):660-4. doi: 10.1016/j.juro.2013.08.088. Epub 2013 Sep 7.

PMID:
24018237
7.

Re: Complications after prostate biopsy: data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2011; 186: 1830-1834.

Ravi P, Sammon J, Meskawi M, Sun M, Karakiewicz PI, Trinh QD.

J Urol. 2012 Aug;188(2):677-8. doi: 10.1016/j.juro.2012.04.021. Epub 2012 Jun 15. No abstract available.

PMID:
22704450
8.
9.

To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.

Kibel AS.

J Urol. 2013 Mar;189(3):796-7. doi: 10.1016/j.juro.2012.12.015. Epub 2012 Dec 12. No abstract available.

PMID:
23246850
10.

Re: To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy: A. S. Kibel J Urol 2013; 189: 796-797.

Horan AH.

J Urol. 2013 Sep;190(3):1139. doi: 10.1016/j.juro.2013.03.122. Epub 2013 Apr 10. No abstract available.

PMID:
23583228
11.

Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?

Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pépin J.

Eur Urol. 2012 Sep;62(3):453-9. doi: 10.1016/j.eururo.2012.04.044. Epub 2012 May 3.

PMID:
22575912
12.

The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.

Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Penson DF, Gross CP.

J Urol. 2012 Jan;187(1):97-102. doi: 10.1016/j.juro.2011.09.042. Epub 2011 Nov 16.

PMID:
22088337
13.

Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases.

Pinkhasov GI, Lin YK, Palmerola R, Smith P, Mahon F, Kaag MG, Dagen JE, Harpster LE, Reese CT, Raman JD.

BJU Int. 2012 Aug;110(3):369-74. doi: 10.1111/j.1464-410X.2011.10926.x. Epub 2012 Feb 7.

14.

Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer.

Filson CP, Schroeck FR, Ye Z, Wei JT, Hollenbeck BK, Miller DC.

J Urol. 2014 Jul;192(1):75-80. doi: 10.1016/j.juro.2014.01.105. Epub 2014 Feb 8.

PMID:
24518783
15.

Patient and treatment factors associated with complications after prostate brachytherapy.

Chen AB, D'Amico AV, Neville BA, Earle CC.

J Clin Oncol. 2006 Nov 20;24(33):5298-304.

PMID:
17114664
16.

Outcomes of transperineal template-guided prostate biopsy in 409 patients.

Symons JL, Huo A, Yuen CL, Haynes AM, Matthews J, Sutherland RL, Brenner P, Stricker PD.

BJU Int. 2013 Sep;112(5):585-93. doi: 10.1111/j.1464-410X.2012.11657.x. Epub 2013 Apr 3.

17.
18.

Bias due to missing SEER data in D'Amico risk stratification of prostate cancer.

Elliott SP, Johnson DP, Jarosek SL, Konety BR, Adejoro OO, Virnig BA.

J Urol. 2012 Jun;187(6):2026-31. doi: 10.1016/j.juro.2012.01.070. Epub 2012 Apr 11.

PMID:
22498210
19.

Reply by author.

[No authors listed]

J Urol. 2013 Sep;190(3):1140. doi: 10.1016/j.juro.2013.03.138. Epub 2013 Jun 14. No abstract available.

PMID:
23770372
20.

Understanding variation in primary prostate cancer treatment within the Veterans Health Administration.

Nambudiri VE, Landrum MB, Lamont EB, McNeil BJ, Bozeman SR, Freedland SJ, Keating NL.

Urology. 2012 Mar;79(3):537-45. doi: 10.1016/j.urology.2011.11.013. Epub 2012 Jan 13.

PMID:
22245306

Supplemental Content

Support Center